The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...

Geographic atrophy (GA) is an advanced dry form of age-related macular degeneration (AMD). Up to 20% of folks with AMD may get it. While we see GA across all populations and races, it’s more common in ...

This late-stage eye disease can cause irreversible vision loss that can affect your well-being and quality of life. As it slowly — and often quietly — steals your sight, you lose your visual acuity ...

Geographic atrophy (GA) progressed more often in patients with better baseline vision and those with lesions closer to the foveal center, according to a study that could help provide needed treatment ...

SAN ANTONIO — Most people know that as we get older our eyesight becomes a little less clear. But your vision loss that you think is normal, may be an advanced form of macular degeneration, or loss of ...

Maybe you’ve noticed that you can no longer see your friends and family clearly. Or perhaps it’s becoming increasingly hard — if not impossible — to drive yourself to your favorite restaurant.

The "Geographic Atrophy Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.The global ...

Vision loss can reduce your independence and may lead to isolation, anxiety, and depression. Taking steps such as talking with a therapist and seeking support can help you manage your mental health.

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...